X-ZELL is a biotechnology company specializing in cancer cell detection. It develops a platform technology capable of detecting tumour-derived Circulating Endothelial Cells (tCEC) in a blood sample. The company also provides cell lysis, high-gradient magnetic cell separation, and other devices for research and clinical use.